tirzepatide obesity nejm New in the January 30, 2025, issue of NEJM: for Heart Failure and (SUMMIT trial) https://nej.md/4hRGaTY Continuation of Oral Anticoagulation during TAVI (POPular PAUSE TAVI trial) https://nej.md/3XllHys Lentiviral Gene Therapy Tirzepatide for HFpEF and Obesity:

Diabetes therapy: research, treatment and education of diabetes and related disorders, 14 (4), 749766

Salk Institute researchers are burrowing down into the mechanistic details behind how GLP-1 drugs promote viability and stress resistance in pancreatic beta cells

Epub 2011 Jan 5

Our programs combine medical expertise with practical advice, making it easier to stay consistent

Our medical program consist of many unique benefits which include One month of weight loss injections An initial consultation with a physician A 3 week check in call with a physician Concierge medicine through our HIPPA text messaging line A consultation with our medical director is required to discuss side effects, risks, and determine candidacy